Medical Journals

Cellular and Molecular Mechanisms Underlying Lps-associated Myocyte Impairment.

Authors:
  • Tavener Samantha A
  • Kubes Paul

From: Dept. of Physiology and Biophysics, Univ. of Calgary Medical Centre, AB, Canada.

American journal of physiology. Heart and circulatory physiology

  • Publish Date: Feb 2006
  • ISSN: 0363-6135
  • Volume: 290
  • Issue: 2
  • Pages: H800-6
  • Medium: Print
  • Language: English
  • Citation (JAMA): Tavener Samantha A, Kubes Paul, et al. Cellular and Molecular Mechanisms Underlying Lps-associated Myocyte Impairment.. Am. J. Physiol. Heart Circ. Physiol. Feb 2006;290:H800-6

Abstract

Recently we reported that Toll-like receptor 4 (TLR4)-positive immune cells of unknown identity were responsible for the LPS-induced depression of cardiac myocyte shortening. The aim of this study is to identify the TLR4-positive cell type that is responsible for the LPS-induced cardiac dysfunction. Neither neutrophil depletion alone nor mast cell deficiency had any impact on the impairment of myocyte shortening during LPS treatment. In contrast, LPS-treated, macrophage-deficient mice demonstrated a partial reduction in shortening compared with saline-treated, macrophage-deficient mice. Because the removal of macrophages could only partially restore myocyte shortening, we also investigated the effects of removing both neutrophils and macrophages on myocyte shortening. Interestingly, endotoxemic, neutrophil-depleted, and macrophage-deficient mice had completely restored myocyte shortening. Because both macrophages and neutrophils can produce nitric oxide (NO) and TNF-alpha, we examined LPS-treated inducible NO synthase knockout (iNOSKO) mice and TNF receptor (TNFR)-deficient mice. Eliminating both TNFR1 and TNFR2 was required to restore myocyte shortening during LPS treatment, whereas iNOS deficiency had no effect. These data suggest that macrophages and to a lesser degree neutrophils cause cardiac impairment, presumably via TNF-alpha.

Mesh Headings (Keywords): Animals, Endotoxemia, Heart Ventricles, Lipopolysaccharides, Macrophages, Male, Mast Cells, Mice, Mice, Inbred C57BL, Mice, Knockout, Myocardial Contraction, Myocytes, Cardiac, Neutrophils, Nitric Oxide, Nitric Oxide Synthase Type II, Receptors, Tumor Necrosis Factor, Type I, Receptors, Tumor Necrosis Factor, Type II, Toll-Like Receptor 4, Tumor Necrosis Factor-alpha


Check for Full Text / PubMed Unique Identifier (PMID): 16172157


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.